$28.49
Perrigo Company is a drug manufacturers - specialty & generic business based in the US. Perrigo Company shares (PRGO) are listed on the NYSE and all prices are listed in US Dollars. Perrigo Company employs 9,140 staff and has a trailing 12-month revenue of around $4.4 billion.
What's in this guide?
Our top picks for where to buy Perrigo Company stock
How to buy Perrigo Company stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PRGO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Perrigo Company stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Perrigo Company stock price (NYSE: PRGO)
Use our graph to track the performance of PRGO stocks over time.Perrigo Company shares at a glance
Latest market close | $28.57 |
---|---|
52-week range | $24.58 - $33.86 |
50-day moving average | $27.45 |
200-day moving average | $29.83 |
Wall St. target price | $38.50 |
PE ratio | N/A |
Dividend yield | $1.098 (3.79%) |
Earnings per share (TTM) | $-0.83 |
Is it a good time to buy Perrigo Company stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Perrigo Company price performance over time
Historical closes compared with the close of $28.57 from 2024-09-03
1 week (2024-08-29) | -1.48% |
---|---|
1 month (2024-08-05) | -0.45% |
3 months (2024-06-05) | 8.22% |
6 months (2024-03-05) | 4.81% |
1 year (2023-09-05) | -18.90% |
---|---|
2 years (2022-09-02) | -22.24% |
3 years (2021-09-03) | 41.85 |
5 years (2019-09-05) | 46.3789 |
Is Perrigo Company stock undervalued or overvalued?
Valuing Perrigo Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Perrigo Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Perrigo Company's PEG ratio
Perrigo Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.9637. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Perrigo Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Perrigo Company's EBITDA
Perrigo Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $545 million.
The EBITDA is a measure of a Perrigo Company's overall financial performance and is widely used to measure a its profitability.
Perrigo Company financials
Revenue TTM | $4.4 billion |
---|---|
Operating margin TTM | 4.22% |
Gross profit TTM | $1.5 billion |
Return on assets TTM | 1.2% |
Return on equity TTM | -2.42% |
Profit margin | -2.81% |
Book value | $33.32 |
Market Capitalization | $4 billion |
TTM: trailing 12 months
Perrigo Company share dividends
Dividend payout ratio: 47.46% of net profits
Recently Perrigo Company has paid out, on average, around 47.46% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.79% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Perrigo Company shareholders could enjoy a 3.79% return on their shares, in the form of dividend payments. In Perrigo Company's case, that would currently equate to about $1.098 per share.
While Perrigo Company's payout ratio might seem fairly standard, it's worth remembering that Perrigo Company may be investing much of the rest of its net profits in future growth.
Perrigo Company's most recent dividend payout was on 16 September 2024. The latest dividend was paid out to all shareholders who bought their shares by 29 August 2024 (the "ex-dividend date").
Have Perrigo Company's shares ever split?
Perrigo Company's shares were split on a 2:1 basis on 25 August 1993. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Perrigo Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Perrigo Company shares which in turn could have impacted Perrigo Company's share price.
Perrigo Company share price volatility
Over the last 12 months, Perrigo Company's shares have ranged in value from as little as $24.5789 up to $33.8597. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Perrigo Company's is 0.485. This would suggest that Perrigo Company's shares are less volatile than average (for this exchange).
Perrigo Company overview
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services.
Frequently asked questions
What percentage of Perrigo Company is owned by insiders or institutions?Currently 0.329% of Perrigo Company shares are held by insiders and 97.766% by institutions. How many people work for Perrigo Company?
Latest data suggests 9,140 work at Perrigo Company. When does the fiscal year end for Perrigo Company?
Perrigo Company's fiscal year ends in December. Where is Perrigo Company based?
Perrigo Company's address is: The Sharp Building, Dublin, Ireland, D02 TY74 What is Perrigo Company's ISIN number?
Perrigo Company's international securities identification number is: IE00BGH1M568 What is Perrigo Company's CUSIP number?
Perrigo Company's Committee on Uniform Securities Identification Procedures number is: G97822103
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy Mainz Biomed stock (Mainz Biomed)
Steps to owning and managing MYNZ, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Owlet Baby Care stock (Owlet Baby Care)
Steps to owning and managing OWLT, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question